Your browser doesn't support javascript.
loading
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.
Schreiner, Sarah; Berghaus, Natalie; Poos, Alexandra M; Raab, Marc S; Besemer, Britta; Fenk, Roland; Goldschmidt, Hartmut; Mai, Elias K; Müller-Tidow, Carsten; Weinhold, Niels; Hegenbart, Ute; Huhn, Stefanie; Schönland, Stefan O.
Afiliación
  • Schreiner S; Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany.
  • Berghaus N; Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany.
  • Poos AM; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, Germany.
  • Raab MS; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, National Centre for Tumor Diseases (NCT), Heidelberg, Germany.
  • Besemer B; Department of Internal Medicine II, Tübingen University Hospital, Tübingen, Germany.
  • Fenk R; Department of Hematology, Oncology, and Clinical Immunology, Düsseldorf University Hospital, Düsseldorf, Germany.
  • Goldschmidt H; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, National Centre for Tumor Diseases (NCT), Heidelberg, Germany.
  • Mai EK; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, National Centre for Tumor Diseases (NCT), Heidelberg, Germany.
  • Müller-Tidow C; Medical Department V, Heidelberg University Hospital, Heidelberg, Germany.
  • Weinhold N; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, Germany.
  • Hegenbart U; Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany.
  • Huhn S; Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, Germany.
  • Schönland SO; Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany.
Amyloid ; 31(2): 86-94, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38206120
ABSTRACT

BACKGROUND:

AL amyloidosis (AL) results from the misfolding of immunoglobulin light chains (IG LCs). Aim of this study was to comprehensively analyse kappa LC sequences from AL patients in comparison with multiple myeloma (MM).

OBJECTIVE:

We analysed IGKV/IGKJ usage and associated organ tropism and IGKV1/D-33 in terms of mutational analysis and theoretical biochemical properties. MATERIAL AND

METHODS:

cDNA and bulk RNA sequencing of the LCs of AL and MM patients.

RESULTS:

We studied 41 AL and 83 MM patients showing that IGKV1 was most expressed among kappa AL and MM, with higher frequency in AL (80% vs. 53%, p = .002). IGKV3 was underrepresented in AL (10% vs. 30%, p = .014). IGKJ2 was more commonly used in AL than in MM (39% vs. 29%). Patients with IGKV1/D-33 were associated with heart involvement (75%, p = .024). IGKV1/D-33-segments of AL had a higher mutation count (AL = 12.0 vs. MM = 10.0). FR3 and CDR3 were most frequently mutated in both, with a median mutation count in FR3 being the highest (AL = 4.0; MM = 3.5) and one mutation hotspot (FR3 (83I)) for IGKV1/D-33/IGKJ2 was associated with cardiac involvement.

CONCLUSION:

This study confirmed that germline usage has an influence on AL amyloidosis risk and organ involvement.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cadenas kappa de Inmunoglobulina / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Mieloma Múltiple Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Amyloid Asunto de la revista: BIOQUIMICA Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cadenas kappa de Inmunoglobulina / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Mieloma Múltiple Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Amyloid Asunto de la revista: BIOQUIMICA Año: 2024 Tipo del documento: Article País de afiliación: Alemania